Value of the lymphocyte nucleolar parameters for the estimation of therapy effectiveness in chronic diseases with immune lymphocyte involvement.
作者信息
Micu D, Mihăilescu E, Sighetea E, Olinescu V, Constantineanu I
出版信息
Med Interne. 1979 Jul-Sep;17(3):285-91.
PMID:583079
Abstract
摘要
相似文献
1
2
[Betamethasone in the treatment of acute lymphatic leukosis and other lymphoproliferative diseases].
Minerva Med. 1980 Nov 10;71(44):3247-50.
3
[Effectiveness of polychemotherapeutic treatments of lymphoproliferative diseases].[多药联合治疗淋巴增生性疾病的疗效]
Haematologica. 1970;55(7):465-70.
4
[Therapy of hemoblastosis. I. Elements of cytostatic and symptomatic therapy].[血液病的治疗。I. 细胞抑制疗法和对症疗法的要素]
G Clin Med. 1966 Aug;47(8):732-68.
5
[Drug therapy in collagen diseases].[胶原病的药物治疗]
Wiad Lek. 1971 Jul 1;24(13):1279-83.
6
Cyto-nucleo-nucleolar variables estimating the lymphocyte reactivity in chronic internal diseases with immune component.细胞-核-核仁变量评估具有免疫成分的慢性内科疾病中的淋巴细胞反应性。
Med Interne. 1980 Oct-Dec;18(4):407-12.
7
8
9
Zotero 插件